PQE Group Reports Solid Year-End Results, Strengthens Position through Innovation in Pharmaceuticals and Medical Devices
27.1.2026 15:00:00 CET | Business Wire | Press release
Revenue gains, global expansion, industry recognition, and ESG leadership supported continued growth in 2025
2025 represented another successful year for PQE Group, a consulting firm in the Life Sciences industry based in Florence (Italy) that includes more than 2000 employees and 40+ offices worldwide. Recently named "Best Managed Company" by Deloitte Private for the sixth consecutive year, the Group achieved a rise in revenue, which reached € 105 millions in 2025, an increase of 7% compared to the €97,5M millions realized in 2024.
Founded by CEO Gilda D'Incerti in 1998, PQE Group is a women-owned company that has received numerous industry certifications, including ISO/IEC 27001, which is the world's best-known standard for information security, and ISO 9001, which focuses on quality management systems. To enhance its ongoing global expansion efforts, in 2025 PQE further expanded in the APAC Region, continued to strengthen its presence in North America, and established new offices in Latina, Italy and Copenhagen, Denmark. PQE also deepened its commitment to Artificial Intelligence (AI) in 2025, focusing heavily on PQE’s AI and Cybersecurity Services excellence and allocating significant resources to stay abreast of AI technological advancements, trends, and offerings in the Life Sciences industry.
In addition to receiving Deloitte Private’s Best Managed Company 2025 Award, PQE’s achievements and recognitions throughout the year included: Great Place to Work Certification for its US Subsidiary for the fourth consecutive year; Best Life Science Company in Maryland by Stellar Business Awards; Ecovadis Badge for Sustainability Excellence 2026; and recognition among the top 75 ESG performers at the Sustainability Award 2025, receiving the 2025 Sustainability Award Italy, which recognizes PQE’s commitment to ESG, the goals of which are published in its Sustainability Report each year, thereby disclosing detailed information on PQE’s sustainability strategy.
In 2025, PQE enhanced its already knowledgeable, professional SME staff by hiring additional senior level consultants and industry experts in numerous service areas, including the recent appointment of Francesco Minà as new Vice President Operations, who, after two decades spent working in the field of Automation and Operational Excellence for Johnson & Johnson, will now lead the service delivery of PQE Group at global level.
“2025 has been a positive year for PQE Group, a private company, made in Italy, with an international dimension,” said Gilda D’Incerti, PQE Group’s CEO & Founder. “This allows us to be in competition with the biggest consulting companies,” she continued, “and not only because of our global network and substantial number of highly specialized resources. By continuously monitoring industry trends and evolving technologies, we provide high-level solutions at competitive costs, pairing local responsiveness with global expertise, and we are quickly becoming one of the top worldwide consulting companies in the biopharmaceutical and medical device industries.”
As PQE continues to expand its global network, it is very committed to investing in expertise and knowledgeable professionals, delivering innovative and impactful solutions for its clients worldwide, and giving back through meaningful social responsibility initiatives— alongside an on-going commitment to patients’ safety and constant efforts to positively enhance the Life Science industry. On this note, the company is a proud member of the EU-funded Project-COMFORT Consortium that aims to transform healthcare through Patient Centric micro-Sampling (PCmS), a minimally invasive method for collecting and analyzing blood samples outside traditional clinical settings. For this effort, PQE is currently leading the “Work Package 7: Laying the Foundation for the Future”, to engage with the project’s audiences by sharing insights, updates, and outputs such as reports and publications.
About PQE Group
Established in Florence, Italy, in 1998, PQE Group is a woman-owned leading Life Science consulting firm, providing high-quality solutions in GCP, GLP, GMP, and GDP areas to both industry giants and small-mid-size businesses worldwide. With a focus on innovation, efficiency, and sustainability and with a global presence through its 40+ offices located around the world and 2000+ professional employees, PQE Group continues to set industry benchmarks and drive positive change in the Life Science sector. The Group's CEO & Founder, Gilda D'Incerti, has also launched ReSQ-UP, a groundbreaking initiative in the Clinical Research Organizations field, focusing on supporting emerging startups in women's health (FemTech), medical devices, and innovations in the biotech sector.
Visit us at PQE Group: Home - PQE Group , and follow PQE Group on LinkedIn, Instagram and Facebook
Learn more about Project-COMFORT: Home – Project-COMFORT, and follow us on LinkedIn
View source version on businesswire.com: https://www.businesswire.com/news/home/20260127299159/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
State Street, in Collaboration with ADIO, to Create 300+ New Jobs With Launch of New Al Ain Operations Hub27.1.2026 16:15:00 CET | Press release
The expansion further solidifies State Street’s role as a trusted strategic partner in Abu Dhabi’s financial ecosystem, supporting the emirate’s commitment to regional economic diversification and developing next-generation talent in Al Ain. State Street Corporation (NYSE: STT), one of the world’s leading providers of financial services to institutional investors, has signed a support agreement with the Abu Dhabi Investment Office (ADIO) to establish a new operating center in the Al Ain region, Abu Dhabi. The collaboration marks a significant step in State Street’s long-term expansion strategy in the Middle East and UAE and reinforces its role as a strategic partner within the Abu Dhabi Global Market (ADGM) ecosystem. As part of its long-term growth plan in Abu Dhabi and aligning to State Street’s global clients’ increasing presence in Abu Dhabi, the new operating hub will create more than 300 financial services roles over the next four years, providing meaningful career pathways for l
Arc'teryx Appoints Avery Baker Chief Brand Officer27.1.2026 15:00:00 CET | Press release
Technical apparel and equipment brand appoints first-ever Chief Brand Officer and names Tobia Prevedello General Manager, EMEA Arc'teryx Equipment, the global design company specializing in technical high-performance apparel and equipment, today announced the appointment of Avery Baker as its first-ever Chief Brand Officer, a newly created executive role that marks a significant step in the company’s global evolution. Baker joins Arc’teryx as it continues to unlock brand potential, elevate global capabilities, and fuel long-term growth across North America, EMEA, APAC, and Greater China. Additionally, Tobia Prevedello was appointed General Manager, EMEA, bringing more than 20 years of international leadership experience across EMEA and APAC. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260127462809/en/ Avery Baker, Chief Brand Officer As Chief Brand Officer, Baker will report to CEO Stuart Haselden and will lead global bra
Research From Lenovo Reveals AI Is Paying Off, Yet Most CIOs Aren’t Ready for What Comes Next27.1.2026 15:00:00 CET | Press release
CIOs anticipate up to 179% ROI on AI investments, with further efficiencies expected as Agentic AI scalesMore than half of organizations (60%) are in late-stage AI adoption – though only 27% have a comprehensive governance framework in placeOnly 21% of CIOs use Agentic AI today, with half (55%) exploring or piloting use casesHybrid AI emerges as preferred deployment model, used by almost two thirds (62%) Enterprises have moved decisively from AI pilots to scaled implementations, driven by proven benefits and expectations of significant financial returns, according to Lenovo CIO Playbook 2026 with research insights by IDC. Nearly half (46%) of AI proof-of-concepts have already progressed into production, with some organizations projecting returns of $2.79 for every dollar invested. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260127255538/en/ Lenovo CIO Playbook 2026: The Race for Enterprise AI AI is now recognized as a cor
Ypê Deepens Partnership with Rimini Street to Accelerate Agentic AI and Maximize ERP Value27.1.2026 15:00:00 CET | Press release
Powered by Rimini Support™ for SAP and Rimini Agentic UX™, Ypê turns ERP stability into a launchpad for rapid, enterprise-wide Agentic AI innovation Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™, and the leading third-party support provider for Oracle, SAP and VMware software, today announced the expansion of its partnership with Ypê, the Brazilian consumer goods company whose products can be found in over 95% of Brazilian homes. This milestone marks a new phase in Ypê’s AI-first vision to build a frictionless company that delivers exceptional experiences for employees, customers and stakeholders. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260127970457/en/ Ypê Deepens Partnership with Rimini Street to Accelerate Agentic AI and Maximize ERP Value Building the Foundation for Innovation Starts with Support A Rimini Support™ client for its SAP S/4HANA system, Ypê is leveraging Rimini St
Indero CRO and the World Scleroderma Foundation Announce Strategic Collaboration to Advance Early Therapeutic Intervention in Systemic Sclerosis27.1.2026 15:00:00 CET | Press release
Indero is pleased to announce a strategic collaboration with the World Scleroderma Foundation (WSF) to support WSF SHIELD platform trial, a randomized, double-blind, adaptive platform clinical trial designed to evaluate multiple investigational medicinal products (IMPs) for patients meeting VEDOSS criteria. This trial aims to intervene at the earliest stages of systemic sclerosis to improve long-term patient outcomes. This partnership brings together 2 leaders in their respective fields, Indero in clinical trial operations and WSF in Scleroderma research and advocacy, to create a powerful platform for innovation in rheumatology. The WSF SHIELD platform is led by Professor Francesco Del Galdo (Chair) and Professor Dinesh Khanna (Co-PI), with Professor Marco Matucci and Professor Yannick Allanore serving as WSF representatives on the steering committee. For pharmaceutical sponsors and biotech companies, this collaboration represents a unique opportunity to engage with a research initiati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom